Valuation: Medpace Holdings, Inc.

Market Cap 16.48B 14.23B 13.39B 12.17B 22.89B 1,579B 23.22B 157B 61.55B 790B 61.86B 60.52B 2,630B P/E 2026 *
33.6x
P/E 2027 * 30.8x
Enterprise Value 15.67B 13.54B 12.74B 11.58B 21.77B 1,502B 22.09B 149B 58.55B 751B 58.85B 57.57B 2,502B EV / Sales 2026 *
5.5x
EV / Sales 2027 * 5.03x
Free-Float
80.05%
Yield 2026 *
-
Yield 2027 * -
1 day-1.14%
1 week-2.51%
Current month+2.29%
1 month+9.78%
3 months+40.32%
6 months+32.30%
Current year+5.10%
1 week 571.01
Extreme 571.01
602.5
1 month 514.47
Extreme 514.47
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
13/08/26 Sell

Chief Executive Officer

-458 0.0016%
11/08/26 Sell

Director

-1,140 0.0041%
11/08/26 Sell

Chief Executive Officer

-17,610 0.0631%
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%-2.51%+27.52%+136.42% 16.48B
-0.11%-1.67%+1.80%+19.90% 48.63B
+1.89%+5.08%+492.59%+629.24% 46.3B
+1.83%+2.75%+15.61%+91.22% 41.97B
-0.50%-1.56%+24.67%+12.17% 39.51B
-2.74%-7.13%+18.72%+49.04% 31.75B
+0.59%-2.25% - - 16.34B
-0.49%-0.34%+3.45%+29.14% 14B
-2.60%-1.00%+77.85%+40.37% 13.33B
-1.42%+0.89%-6.45%-33.27% 12.89B
Average -0.47%-0.71%+72.86%+108.25% 28.12B
Weighted average by Cap. -0.06%-0.30%+100.33%+146.24%

Financials

2026 *2027 *
Net sales 2.85B 2.46B 2.32B 2.11B 3.96B 273B 4.02B 27.18B 10.65B 137B 10.71B 10.47B 455B 3.03B 2.61B 2.46B 2.24B 4.2B 290B 4.27B 28.85B 11.31B 145B 11.36B 11.12B 483B
Net income 503M 434M 408M 371M 698M 48.15B 708M 4.79B 1.88B 24.08B 1.89B 1.85B 80.22B 547M 472M 444M 404M 759M 52.37B 770M 5.21B 2.04B 26.19B 2.05B 2.01B 87.25B
Net Debt -802M -693M -652M -593M -1.11B -76.87B -1.13B -7.65B -3B -38.45B -3.01B -2.95B -128B -1.25B -1.08B -1.02B -925M -1.74B -120B -1.76B -11.94B -4.68B -60B -4.7B -4.6B -200B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
18/08/26 $590.30 -1.14% 131,427
17/08/26 $597.12 +3.22% 163,938
14/08/26 $578.50 -0.59% 220,619
13/08/26 $581.95 -2.52% 151,061
12/08/26 $596.98 -1.41% 310,387
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
590.30USD
Average target price
581.83USD
Spread / Average Target
-1.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock